SMN2 and proximal spinal muscular atrophy: The participants were divided into 2 cohorts based on their SMN2 copy number: Cohort 1 (14 infants with 2 copies of SMN2 expected to develop SMA) and Cohort 2 (15 infants with 3 copies of SMN2 expected to develop SMA).